Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia C Jones

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Plos One|February 17, 2017
Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injuryGerardo M Castillo, Akiko Nishimoto-Ashfield, Cynthia C Jones, et al.
Brain & Development|September 4, 2020
Natural history in spinal muscular atrophy Type I in Taiwanese population: A longitudinal studyShan-Fu Ou, Che-Sheng Ho, Wang-Tso Lee, et al.
Journal of Neuromuscular Diseases|November 11, 2019
Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA CohortCynthia C Jones, Suzanne F Cook, Jill Jarecki, et al.
Journal of Neuromuscular Diseases|April 5, 2018
An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA membersLisa Belter, Suzanne F Cook, Thomas O Crawford, et al.
Journal of Neurology|June 22, 2017
A multi-source approach to determine SMA incidence and research ready populationIngrid E C Verhaart, Agata Robertson, Rebecca Leary, et al.
Orphanet Journal of Rare Diseases|July 6, 2017
Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature reviewIngrid E C Verhaart, Agata Robertson, Ian J Wilson, et al.
Neurology and Therapy|May 31, 2020
Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEMAngel Chinea, Lilyana Amezcua, Wendy Vargas, et al.
Neurology and Therapy|May 31, 2020
Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEMMitzi J Williams, Lilyana Amezcua, Annette Okai, et al.
Clinical and Vaccine Immunology : CVI|July 17, 2009
Single-antigen serological testing for bovine tuberculosisLawrence R Green, Cynthia C Jones, Anne L Sherwood, et al.
Journal of Neuromuscular Diseases|October 26, 2020
The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular AtrophyLisa Belter, Jill Jarecki, Sandra P Reyna, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Plos One|February 17, 2017
Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injuryGerardo M Castillo, Akiko Nishimoto-Ashfield, Cynthia C Jones, et al.
Brain & Development|September 4, 2020
Natural history in spinal muscular atrophy Type I in Taiwanese population: A longitudinal studyShan-Fu Ou, Che-Sheng Ho, Wang-Tso Lee, et al.
Journal of Neuromuscular Diseases|November 11, 2019
Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA CohortCynthia C Jones, Suzanne F Cook, Jill Jarecki, et al.
Journal of Neuromuscular Diseases|April 5, 2018
An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA membersLisa Belter, Suzanne F Cook, Thomas O Crawford, et al.
Journal of Neurology|June 22, 2017
A multi-source approach to determine SMA incidence and research ready populationIngrid E C Verhaart, Agata Robertson, Rebecca Leary, et al.
Orphanet Journal of Rare Diseases|July 6, 2017
Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature reviewIngrid E C Verhaart, Agata Robertson, Ian J Wilson, et al.
Neurology and Therapy|May 31, 2020
Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEMAngel Chinea, Lilyana Amezcua, Wendy Vargas, et al.
Neurology and Therapy|May 31, 2020
Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEMMitzi J Williams, Lilyana Amezcua, Annette Okai, et al.
Clinical and Vaccine Immunology : CVI|July 17, 2009
Single-antigen serological testing for bovine tuberculosisLawrence R Green, Cynthia C Jones, Anne L Sherwood, et al.
Journal of Neuromuscular Diseases|October 26, 2020
The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular AtrophyLisa Belter, Jill Jarecki, Sandra P Reyna, et al.
Pageof 2